Published online before print April 8, 2004, doi: 10.1161/01.STR.0000126118.44249.5c
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:1482.)
© 2004 American Heart Association, Inc.
Comments, Opinions, and Reviews |
Therapeutic Hypothermia for Acute Ischemic Stroke
What Do Laboratory Studies Teach Us?
From Department of Neurology (D.W.K.), The Cleveland Clinic Foundation, Cleveland, Ohio; and Departments of Neurology and Neurological Sciences and Neurosurgery (M.A.Y.), Stanford University School of Medicine, Stanford, Calif.
Correspondence to Dr Derk W. Krieger, Section of Stroke and Neurological Intensive Care, Desk S-91, Dept. of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195. E-mail krieged{at}ccf.org
Background and Purpose— The significance of brain temperature to outcome in cerebral ischemia is recognized. Numerous variations of depth, duration, and delay of cooling have been studied in animal models. It is important to become familiar with these studies to design appropriate clinical trials. With that in mind, a critical review of the pertinent literature is presented, taking into consideration potential limitations in translating such laboratory work to the clinical level.
Methods— Hypothermia is an especially robust neuroprotectant in the laboratory and has been shown to alter many of the damaging effects of cerebral ischemia. Most laboratory research on therapeutic cooling in cerebral ischemia has been conducted in rodent models of temporary and permanent middle cerebral artery occlusion and report the effects of mild or moderate hypothermia arranged during or after ischemia.
Results— Intraischemic cooling vastly reduces infarct size in most occlusion models. Tissue salvage with delayed onset of cooling is less dramatic but is commonly observed when cooling is begun within 60 minutes of stroke onset in permanent and 180 minutes of stroke onset in temporary occlusion models. Prolonged postischemic cooling further enhances efficacy.
Conclusions— Laboratory studies have shown that intraischemic hypothermia is more protective than postischemic hypothermia and more benefit is conferred with temporary occlusion than permanent occlusion models. The efficacy of postischemic hypothermia is critically dependent on the duration and depth of hypothermia and its timing relative to ischemia.
Key Words: animal models • middle cerebral artery occlusion • hypothermia • ischemia
This article has been cited by other articles:
 |
|
 |
|
  B. Karaszewski, J. M. Wardlaw, I. Marshall, V. Cvoro, K. Wartolowska, K. Haga, P. A. Armitage, M. E. Bastin, and M. S. Dennis Early brain temperature elevation and anaerobic metabolism in human acute ischaemic stroke Brain, April 3, 2009; (2009) awp010v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Hemmen and P. D. Lyden Multimodal Neuroprotective Therapy With Induced Hypothermia After Ischemic Stroke Stroke, March 1, 2009; 40(3_suppl_1): S126 - S128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Alberts, R. A. Felberg, L. R. Guterman, S. R. Levine, and for Writing Group 4 Atherosclerotic Peripheral Vascular Disease Symposium II: Stroke Intervention: State of the Art Circulation, December 16, 2008; 118(25): 2845 - 2851. [Full Text] [PDF]
|
|
|
|
|
|
M. Yenari, K. Kitagawa, P. Lyden, and M. Perez-Pinzon Metabolic Downregulation: A Key to Successful Neuroprotection? Stroke, October 1, 2008; 39(10): 2910 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Antonelli, M. C. Tomasini, J. Fournier, R. Mazza, S. Tanganelli, S. Pirondi, K. Fuxe, and F. Luca Neurotensin Receptor Involvement in the Rise of Extracellular Glutamate Levels and Apoptotic Nerve Cell Death in Primary Cortical Cultures after Oxygen and Glucose Deprivation Cereb Cortex, August 1, 2008; 18(8): 1748 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. van der Worp, E. S. Sena, G. A. Donnan, D. W. Howells, and M. R. Macleod Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis Brain, December 1, 2007; 130(12): 3063 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. REPRINT: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, October 16, 2007; 116(16): e391 - e413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Doyle, K. L. Suchland, T. M.P. Ciesielski, N. S. Lessov, D. K. Grandy, T. S. Scanlan, and M. P. Stenzel-Poore Novel Thyroxine Derivatives, Thyronamine and 3-iodothyronamine, Induce Transient Hypothermia and Marked Neuroprotection Against Stroke Injury Stroke, September 1, 2007; 38(9): 2569 - 2576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Broderick, S. Connolly, E. Feldmann, D. Hanley, C. Kase, D. Krieger, M. Mayberg, L. Morgenstern, C. S. Ogilvy, P. Vespa, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults: 2007 Update: A Guideline From the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke, June 1, 2007; 38(6): 2001 - 2023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Hemmen and P. D. Lyden Induced Hypothermia for Acute Stroke Stroke, February 1, 2007; 38(2): 794 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dawson and M. Walters New and emerging treatments for stroke Br. Med. Bull., November 7, 2006; (2006) ldl011v1. [Abstract] [Full Text] [PDF]
|
|